Business, People

Sanofi fires back at Roseanne: ‘racism is not a side effect’ of Ambien

In the sobering daylight after Roseanne Barr tweeted a racist jab at one of Barack Obama’s senior advisors, Barr is blaming her bad behavior on a late-night dose of Ambien. But the drug’s maker Sanofi is throwing off the association, taking to Twitter to raise an eyebrow at Barr’s defense.


Barr’s offensive tweet was directed at Valerie Jarrett, an African-American woman who was one of Obama’s top advisors during his presidency. Although quickly deleted from her account, the tweet was saved in perpetuity via screengrab and shared all over the internet.

The tweet got Barr’s new show — a renewed take on the popular “Roseanne” sitcom —immediately canceled, even after a successful first season. The show brought in an estimated $45 million in ad revenue for ABC, and was expected to bring in $60 million in its next season. But that ad revenue will never come, as Channing Dungey, president of ABC Entertainment explained.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 34,800+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biotech Investment Analyst
SV Health Investors Boston, MA
Research Scientist - Disease Biology
Recursion Pharmaceuticals Salt Lake City, UT
Senior Scientist - Predictive Pharmacology
Recursion Pharmaceuticals Salt Lake City, UT
Director, Translational Sciences
Cadent Therapeutics Cambridge, MA
Director of Marketing
twoXAR Mountain View, CA

Visit Endpoints Careers ->